Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2004 Jun;19(2):132-3.
doi: 10.3904/kjim.2004.19.2.132.

Nail changes during docetaxel containing combination chemotherapy

In Sook Woo  1 , Kon Ho Shim, Gi Young Kim, Myung Ah Lee, Jin Hyoung Kang, Young Seon Hong, Kyung Shik Lee
Affiliations
Case Reports

Nail changes during docetaxel containing combination chemotherapy

In Sook Woo et al. Korean J Intern Med. 2004 Jun.

Abstract

Nail toxicity following systemic chemotherapy is common. Onychopathy during the period of neutropenia following chemotherapy may cause subungual abscesses and serious infection. Despite taxoid-related toxicity being increasingly reported since 2000, there are still phase II systemic chemotherapy studies using taxoid that have never mentioned nail changes. Recently, new criteria for the evaluation of nail toxicity have been suggested. The present report is the first of its kind, in Korea, to describe a case of docetaxel-associated onychopathy, which improved following a reduction in the docetaxel dose.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Brown pigmentation and Beau’s lines are noted on the finger nail beds.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Hussain S, Anderson DN, Salvatti ME, Adamson B, McManus M, Braverman AS. Onycholysis as a complication of systemic chemotherapy: report of five cases associated with prolonged weekly paclitaxel therapy and review of the literature. Cancer. 2000;88:2367–2371. - PubMed
    1. Minisini AM, Tosti A, Sobrero AF, Mansutti M, Piraccini BM, Sacco C. Puglisi Taxane-induced nail changes: incidence, clinical presentation and outcome. Ann Oncol. 2003;14:333–337. - PubMed
    1. Hainsworth JD, Burris HA, 3rd, Yardley DA, Bradof JE, Grimaldi M, Kalman LA, Sullivan T, Baker M, Erland JB, Greco FA. Weekly docetaxel in the treatment of elderly patients with advanced breast cancer. J Clin Oncol. 2001;19:3500–3505. - PubMed
    1. Perez EA, Vogel CL, Irwin DH, Kirshner JJ, Patel R. Multlcenter phase II trial of weekly paclitaxel in women with metastatic breast cancer. J Clin Oncol. 2001;19:4216–4223. - PubMed
    1. Spazzapan S, Crivellari D, Lombardi D, Scuderi C, Magri MD, Veronesi A, Gatti AJ. Nail toxicity related to weekly taxanes: an important issue requiring a change in common toxicity criteria grading? J Clin Oncol. 2002;20:4404–4405. - PubMed

Publication types

MeSH terms